|
|
 |
 |
|
|
|
|
 |
|
|
|
|
|
|
|
表 題 |
著者名 |
誌
名 |
| Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate. |
Otsubo S, Yokomizo A, Mochida O, Shiota M, Tatsugami K, Inokuchi J, Naito S: |
World J Urol 33 (3): 329-333, 2015 |
| The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy. |
Shiota M, Yokomizo A, Takeuchi A, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Naito S: |
J Cancer Res Clin Oncol 141 (3):495-503, 2015 |
| Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation. |
Takeuchi A, Eto M, Tatsugami K, Yamada H, Yokomizo A, Shiota M, Itsumi M, Inokuchi J, Kiyoshima K, Dejima T, Imada K, Naito S, Yoshikai Y: |
Transpl Immunol 32 (2): 131-139, 2015 |
| Non-inferiority of silodosin 4?mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: a multicenter, randomized, parallel-group study. |
Seki N, Takahashi R, Yamaguchi A, Ito K, Takayama K, Nanri K, Kamiryo Y, Yamashita H, Komine S, Miyazaki Y, Uozumi J, Naito S: |
Int J Urol 22 (3): 311-316, 2015 |
| Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer. |
Cordonnier T, Bishop JL, Shiota M, Nip KM, Thaper D, Vahid S, Heroux D, Gleave M, Zoubeidi A: |
Int J Cancer 136 (6): E496-E507, 2015 |
| Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats. |
Funahashi Y, Wang Z, O'Malley KJ, Tyagi P, DeFranco DB, Gingrich JR, Takahashi R, Majima T, Gotoh M, Yoshimura N: |
Prostate 75 (4): 381-389, 2015 |
| Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer. |
Shiota M, Bishop JL, Takeuchi A, Nip KM, Cordonnier T, Beraldi E, Kuruma H, Gleave ME, Zoubeidi A: |
Oncotarget 6 (11): 9086-9098, 2015
|
| C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. |
Maeda Y, Kawano Y, Wada Y, Yatsuda J, Motoshima T, Murakami Y, Kikuchi K, Imamura T, Eto M: |
Oncol Rep 33 (4): 1844-1850, 2015 |
| Laparoscopic en bloc excision of gastrointestinal stromal tumors of the rectum after neoadjuvant imatinib therapy: anteriorly extended intersphincteric resection combined with partial resection of the prostate. |
Ueki T, Nagayoshi K, Manabe T, Maeyama R, Yokomizo A, Yamamoto H, Oda Y, Tanaka M: |
Tech Coloproctol (4): 247-251, 2015 |
| Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy. |
Shinohara N, Obara W, Tatsugami K, Naito S, Kamba T, Takahashi M, Murai S, Abe T, Oba K, Naito S: |
Cancer Sci 106 (5): 618-626, 2015 |
| Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy. |
Shiota M, Yokomizo A, Takeuchi A, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Ohga S, Nakamura K, Honda H, Naito S: |
Oncotarget 6 (16): 14710-14719, 2015 |
| Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells. |
Motoshima T, Komohara Y, Horlad H, Takeuchi A, Maeda Y, Tanoue K, Kawano Y, Harada M, Takeya M, Eto M: |
Oncol Rep 33 (6): 2947-2953, 2015 |
| Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era. |
Tatsugami K, Shinohara N, Kondo T, Yamasaki T, Eto M, Tsushima T, Terachi T, Naito S; Japanese Society of Renal Cancer: |
Int J Urol 22 (8): 736-740, 2015 |
| Nuclear redox imbalance affects circadian oscillation in HaCaT keratinocytes. |
Ranieri D, Avitabile D, Shiota M, Yokomizo A, Naito S, Bizzarri M, Torrisi MR: |
Int J Biochem Cell Biol 65: 113-124, 2015 |
| The Advantage of a Ureteroscopic Navigation System with Magnetic Tracking in Comparison with Simulated Fluoroscopy in a Phantom Study. |
Yoshida K, Yokomizo A, Matsuda T, Hamasaki T, Kondo Y, Yamaguchi K, Kanayama HO, Wakumoto Y, Horie S, Naito S: |
J Endourol 29 (9): 1059-1064, 2015 |
| Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma. |
Naito S, Sakai H, Hashine K, Tomita Y, Shinohara N, Fujisawa M, Eto M, Ozono S, Akaza H: |
Ann Oncol 26 (9): 1871-1876, 2015 |
| SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy. |
Shiota M, Fujimoto N, Yokomizo A, Takeuchi A, Itsumi M, Inokuchi J, Tatsugami K, Uchiumi T, Naito S: |
Eur J Cancer 51 (14): 1962-1969, 2015 |
| Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association. |
Kanayama HO, Fukumori T, Fujimoto H, Nakanishi H, Ohyama C, Suzuki K, Nishiyama H, Eto M, Miki T, Kamoi K, Kubota Y, Takahashi S, Homma Y, Naito S: |
Int J Urol 22 (9): S1-S7, 2015 |
| Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan. |
Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators: |
BMC Cancer 15: 667, 2015 |
| Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer. |
Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Kamba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K, Kakehi Y: |
Int J Clin Oncol 20 (5): 1026-1034, 2015 |
| Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database. |
Miyazaki J, Nishiyama H, Fujimoto H, Ohyama C, Koie T, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T; Cancer Registration Committee of the Japanese Urological Association: |
Int J Urol 22 (11): 1023-1027, 2015 |
| Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association. |
Hara T, Fujimoto H, Sakura M, Inokuchi J, Nishiyama H, Miyazaki J, Ohyama C, Koie T, Kikuchi E, Hinotsu S; Cancer Registration Committee of the Japanese Urological Association: |
Int J Urol 22 (11): 1013-1020, 2015 |
| Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml. |
Shiota M, Takeuchi A, Sugimoto M, Dejima T, Kashiwagi E, Kiyoshima K, Inokuchi J, Tatsugami K, Yokomizo A |
Anticancer Res 35 (11): 6137-6145, 2015 |
| Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer. |
Shiota M, Itsumi M, Takeuchi A, Imada K, Yokomizo A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S: |
Endocr Relat Cancer 22 (6): 889-900, 2015 |
| Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer. |
Shiota M, Takeuchi A, Sugimoto M, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Yokomizo A: |
Anticancer Res 35 (12): 6925-6932, 2015 |
| Mechanisms inducing autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury. |
Yoshizawa T, Kadekawa K, Tyagi P, Yoshikawa S, Takahashi R, Takahashi S, Yoshimura N: |
Spinal Cord, 53: 190-194, 2015 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
